EICHOR
● Active Not Recruiting
Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL
Condition: Diffuse Large B-cell Lymphoma · Sponsor: Seagen, a wholly owned subsidiary of Pfizer
About this study
Participants in this study will have diffuse large B-cell lymphoma (DLBCL) that has come back or not gotten better with treatment. The trial will study whether brentuximab vedotin plus two drugs works better to treat this type of cancer than the two drugs alone. Participants will be randomly assigned to get either brentuximab vedotin or placebo. The placebo will look like brentuximab vedotin, but has no medicine in it. Since the study is "blinded," participants and their doctors will not know whether a participant gets brentuximab vedotin or placebo. All participants in the study will get rituximab and lenalidomide. These are drugs that can be used to treat DLBCL.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (143)
| Central Alabama Research | Birmingham, Alabama, United States | — |
| University of California Davis Comprehensive Cancer Center | Sacramento, California, United States | — |
| University of California Davis Medical Center | Sacramento, California, United States | — |
| Florida Cancer Specialists | Bonita Springs, Florida, United States | — |
| Florida Cancer Specialists | Bradenton, Florida, United States | — |
| Florida Cancer Specialists | Cape Coral, Florida, United States | — |
| Florida Cancer Specialists | Daytona Beach, Florida, United States | — |
| Florida Cancer Specialists | Fort Myers, Florida, United States | — |
| Florida Cancer Specialists | Fort Myers, Florida, United States | — |
| Florida Cancer Specialists | Naples, Florida, United States | — |
| Florida Cancer Specialists | Port Charlotte, Florida, United States | — |
| Florida Cancer Specialists | Sarasota, Florida, United States | — |
+ 131 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04404283